Skip to main content
Fig. 2 | Arthritis Research & Therapy

Fig. 2

From: Site-specific resolution of enthesitis in patients with axial spondyloarthritis treated with tumor necrosis factor inhibitors

Fig. 2

mMASES at Baseline and (A) 6 or (B) 12 Months. Each line on the plot connects the before and after mMASES values of a treatment course. More than one treatment course may have overlapping lines. The line colours indicate whether mMASES reduced, increased, or stayed the same. The numbers at baseline and the 6-month and 12-month time points indicate the number of TCs with the corresponding score. The black line indicates the evolution of the mean mMASES score between the 2 time points. For the assessment of modified MASES at the 6-month time point, values in interval [6 ± 3 months] were used and at the 12-month time point, values in interval [12 ± 3 months] were used. mMASES, modified Maastricht ankylosing spondylitis enthesitis score (modified to include the plantar fascia); TC, treatment course; TNFi, tumor necrosis factor inhibitor

Back to article page